Literature DB >> 11093910

Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus.

M Chikuma1, S Masuda, T Kobayashi, M Nagao, R Sasaki.   

Abstract

Erythropoietin (Epo) produced by the kidney regulates erythropoiesis. Recent evidence suggests that Epo in the cerebrum prevents neuron death and Epo in the uterus induces estrogen (E(2))-dependent uterine angiogenesis. To elucidate how Epo expression is regulated in these tissues, ovariectomized mice were given E(2) and/or exposed to hypoxia, and the temporal patterns of Epo mRNA levels were examined. Epo mRNA levels in the kidney and cerebrum were elevated markedly within 4 h after exposure to hypoxia. Although the elevated level of Epo mRNA in the kidney decreased markedly within 8 h despite continuous hypoxia, the high level in the cerebrum was sustained for > or = 24 h, indicating that downregulation operates in the kidney but not in the brain. E(2) transiently induced Epo mRNA in the uterus but not in the kidney and cerebrum. Interestingly, the uterine Epo mRNA was hypoxia inducible only in the presence of E(2). Thus Epo expression appears to be regulated in a tissue-specific manner, endorsing the tissue-specific functions of Epo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093910     DOI: 10.1152/ajpendo.2000.279.6.E1242

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  36 in total

1.  Erythropoietin Attenuates the Apoptosis of Adult Neurons After Brachial Plexus Root Avulsion by Downregulating JNK Phosphorylation and c-Jun Expression and Inhibiting c-PARP Cleavage.

Authors:  Kai Li; Rang-Juan Cao; Xiao-Juan Zhu; Xing-Yu Liu; Long-Yun Li; Shu-Sen Cui
Journal:  J Mol Neurosci       Date:  2015-04-16       Impact factor: 3.444

2.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

3.  Erythropoietin neuroprotection with traumatic brain injury.

Authors:  Lucido L Ponce; Jovany Cruz Navarro; Osama Ahmed; Claudia S Robertson
Journal:  Pathophysiology       Date:  2012-03-14

4.  Human erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.

Authors:  Youngsook Lee; Hye Yeong Nam; Jaesung Kim; Minhyung Lee; James W Yockman; Sug Kyun Shin; Sung Wan Kim
Journal:  Mol Ther       Date:  2012-04-03       Impact factor: 11.454

5.  Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury.

Authors:  Masanori Iwai; R Anne Stetler; Juan Xing; Xiaoming Hu; Yanqin Gao; Wenting Zhang; Jun Chen; Guodong Cao
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

Review 6.  Mechanisms of testicular torsion and potential protective agents.

Authors:  Ersagun Karaguzel; Mustafa Kadihasanoglu; Omer Kutlu
Journal:  Nat Rev Urol       Date:  2014-06-17       Impact factor: 14.432

Review 7.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 8.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

9.  A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury.

Authors:  Alberto Pinzon; Alexander Marcillo; Diego Pabon; Helen M Bramlett; Mary Bartlett Bunge; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2008-07-14       Impact factor: 5.330

Review 10.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.